Optimum conditions for efficient phagocytosis of rifampicin-loaded PLGA microspheres by alveolar macrophages.
about
Delivery of host cell-directed therapeutics for intracellular pathogen clearanceValue of phagocyte function screening for immunotoxicity of nanoparticles in vivoSystems Pharmacology Approach Toward the Design of Inhaled Formulations of Rifampicin and Isoniazid for Treatment of TuberculosisComparison of fluorescence-based methods to determine nanoparticle uptake by phagocytes and non-phagocytic cells in vitro.In vitro analysis of acetalated dextran microparticles as a potent delivery platform for vaccine adjuvants.Acetalated dextran encapsulated AR-12 as a host-directed therapy to control Salmonella infection.Needle-Free Delivery of Acetalated Dextran-Encapsulated AR-12 Protects Mice from Francisella tularensis Lethal Challenge.Rapid vaccination using an acetalated dextran microparticulate subunit vaccine confers protection against triplicate challenge by bacillus anthracis.Biomimetic Concealing of PLGA Microspheres in a 3D Scaffold to Prevent Macrophage Uptake.Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug.Acid-degradable polyurethane particles for protein-based vaccines: biological evaluation and in vitro analysis of particle degradation products.Inhalative nanomedicine--opportunities and challenges.Fighting tuberculosis: old drugs, new formulations.Drug delivery systems for intra-articular treatment of osteoarthritis.Macrophage-specific targeting of isoniazid through mannosylated gelatin microspheres.Next generation vaccines: single-dose encapsulated vaccines for improved global immunisation coverage and efficacy.Nano- and micro-based inhaled drug delivery systems for targeting alveolar macrophages.Rifampicin loaded mannosylated cationic nanostructured lipid carriers for alveolar macrophage-specific delivery.(89)Zr-labeled anti-endoglin antibody-targeted gold nanoparticles for imaging cancer: implications for future cancer therapy.Application of a four-fluid nozzle spray drier to prepare inhalable rifampicin-containing mannitol microparticles.Selective local delivery of RANK siRNA to bone phagocytes using bone augmentation biomaterials.Inhaled microparticles of antitubercular antibiotic for in vitro and in vivo alveolar macrophage targeting and activation of phagocytosis.Preparation of sustained release rifampicin microparticles for inhalation.Synthesis, characterization and in vitro extracellular and intracellular activity against Mycobacterium tuberculosis infection of new second-line antitubercular drug-palladium complexes.Modulating the immune system through nanotechnology.Cefquinome-loaded microsphere formulations against Klebsiella pneumonia infection during experimental infections.Particulate transepithelial drug carriers: barriers and functional polymers
P2860
Q27006858-CD6F37CE-5853-4505-B0D3-166A94DC2588Q28084932-C8CB12BB-9987-4C11-8BAB-A66711E1B510Q28649769-92E3A16E-FAF6-4C24-AC2C-9B8680005164Q33618992-9DDD1FBA-D101-41BB-A7B9-4B86091C7B95Q33901007-C1619E0C-D1E6-4FDC-9537-783774B108C7Q34450753-10E1EDAA-27D2-49EE-BD08-1AD528FEC5EDQ34509909-6E139284-6395-4313-A1F3-72A8830853B4Q34564854-6DC8E261-9935-406C-AE99-C9A8DD6ABECFQ35900798-686206EF-AF64-4066-A035-2AAF42F1E39EQ36459188-8E0E31B7-318E-4ED3-8910-260756A103EDQ37115425-02A4E25A-C856-4727-8E94-5EE487123F9AQ37532479-02A47177-0C29-4AC7-BF45-AD270A24AF34Q37579212-70074671-1E23-41D1-817A-EE156261DCDDQ38168885-EE509CFA-7AF3-4FA4-BED9-00D71084F4FFQ38311993-A93500B4-203E-4405-8974-59797EBE698CQ38341522-17EC7D03-AC19-419E-9A0A-CCBF7388C0ABQ38442447-EBA57419-32F8-41B7-8A95-EB2009573DB7Q38939434-B417ACE8-472A-4EAD-BDC1-14049DA35B47Q39023017-F69A44F6-72F4-4C26-ABBF-A0B26ADB349BQ41989537-6C490E74-FA80-4BEF-9CE5-C5C29728C62DQ42052780-18DFE16B-496A-40ED-856A-56D31592D66BQ42227059-F2746908-6319-4FCA-8F6A-8A2E3BAE609CQ44977937-9DEC57CC-48C2-456C-8232-B7A54398DB4BQ46959020-48B13513-0A6A-4177-9152-01B2498C09DFQ48630939-015657F7-B54A-4B17-8AAE-FA2224299801Q54236833-3A32F439-4D33-4887-9B59-B81EEDF6EE4EQ58385253-53ECE8ED-60C2-47AC-A6DD-B613CAE19FF9
P2860
Optimum conditions for efficient phagocytosis of rifampicin-loaded PLGA microspheres by alveolar macrophages.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Optimum conditions for efficie ...... heres by alveolar macrophages.
@en
Optimum conditions for efficie ...... heres by alveolar macrophages.
@nl
type
label
Optimum conditions for efficie ...... heres by alveolar macrophages.
@en
Optimum conditions for efficie ...... heres by alveolar macrophages.
@nl
prefLabel
Optimum conditions for efficie ...... heres by alveolar macrophages.
@en
Optimum conditions for efficie ...... heres by alveolar macrophages.
@nl
P2093
P1476
Optimum conditions for efficie ...... heres by alveolar macrophages.
@en
P2093
Chie Kochi
Fuminori Ito
Gen-Ichiro Soma
Hideyuki Hinata
Hiroshi Terada
Hiroyuki Inagawa
Keiji Hirota
Kimiko Makino
Taizo Hasegawa
P356
10.1016/J.JCONREL.2007.01.013
P407
P577
2007-02-01T00:00:00Z